Cargando…
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens – genetically governed antigenic determinants – at...
Autores principales: | Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J., Heldring, Nina, Hamad, Osama A., Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E., Olsson, Martin L., Le Blanc, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890285/ https://www.ncbi.nlm.nih.gov/pubmed/24454787 http://dx.doi.org/10.1371/journal.pone.0085040 |
Ejemplares similares
-
A new missense variant in exon 7 of the
ABO
gene, c.662G>A, in a family with B(w) phenotype
por: Hult, Annika K., et al.
Publicado: (2022) -
ABO Blood Groups Influence Macrophage-mediated Phagocytosis of Plasmodium falciparum-infected Erythrocytes
por: Wolofsky, Kayla T., et al.
Publicado: (2012) -
Crippled Children's Hampers
por: Treloar, W. P.
Publicado: (1906) -
Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies
por: Nilsson, Ulf R., et al.
Publicado: (2011) -
Mesenchymal Stromal Cell Secretion of Programmed Death‐1 Ligands Regulates T Cell Mediated Immunosuppression
por: Davies, Lindsay C., et al.
Publicado: (2016)